Adverse reactions to gefitinib (Iressa): revealing sycosis- and pyoderma gangrenosum-like lesions.
Sagara
Rei
R
Kitami
Amane
A
Nakada
Tokio
T
Iijima
Masafumi
M
D000970:Antineoplastic Agents / Q000009:adverse effects*; D005499:Folliculitis / Q000139:chemically induced* / Q000473:pathology*; D000077156:Gefitinib; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D017511:Pyoderma Gangrenosum / Q000139:chemically induced* / Q000473:pathology*; D011799:Quinazolines / Q000009:adverse effects*
D000970:Antineoplastic Agents; D011799:Quinazolines; D000077156:Gefitinib